Alimta package insert

Alimta [package insert]. Indianapolis, IN; Eli Lilly; January 2024. Accessed April 2024. 2. Referenced with permission from the NCCN Drugs

12 Alimta Product Package Insert. Eli Lilly and Company. Indianapolis, Indiana. August 2024. 13 Niyikiza C. baker SD, Seitz DE, Walling JM

by X Li 2024 Cited by 21Pemetrexed is a very costly drug. Since nonsquamous NSCLC ALIMTA [package insert] Indianopolis, IN: Eli Lilly and Company; 2024.

by BR Griffin 2024 Cited by 7The Food and Drug Administration's patient package insert for pemetrexed (Alimta) reads as follows [1]: 'You must start taking ,000 mcg

Based on the package insert, there is a potential for a significant interaction of NSAIDs with Alimta, specifically that they can slow

of ALIMTA administration. Patients should receive appropriate hydration prior to and/or after receiving cisplatin. See cisplatin package insert for more information. 2.2 Single-Agent Use Nonsquamous Non-Small Cell Lung Cancer The recommended dose of ALIMTA is 500 mg/m 2 administered as an intravenous infusion over 10 minutes on Day 1 of each

Brief patient counseling information can be found in the Pemetrexed (Alimta) package insert

Alimta 500 mg powder for injection; single-use vial: xx Pemfexy 500 mg/20 mL solution for injection, single-use vial: xx VII. References 1. Alimta [package insert]. Indianapolis, IN; Eli Lilly; January 2024. Accessed July 2024. 2. Pemfexy [package insert]. Woodcliff Lake, NJ; Eagle Pharmaceuticals, Inc; February 2024.

Requests for Alimta (pemetrexed disodium) may be approved if the following criteria are met: Package inserts. U.S. National Library of Medicine, National